PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$300.65
+1.78 (+0.60%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+518.62%
YTD
+4.98%
Open$300.19
Previous Close$298.87
Day High$312.46
Day Low$298.40
52W High$392.70
52W Low$41.78
Volume—
Avg Volume308.9K
Market Cap8.52B
P/E Ratio—
EPS$-13.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$296.27
Above
SMA 200
$133.67
Above
RSI (14)
61.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
-93.5% upside
Current
$300.65
$300.65
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.03M | 1.51B | 1.36B |
| Net Income | -278,552,680 | -397,237,584 | -445,831,143 |
| Profit Margin | -2,137.5% | -26.4% | -32.9% |
| EBITDA | -304,436,703 | -626,558,933 | -546,408,810 |
| Free Cash Flow | — | -309,826,002 | -348,261,984 |
| Rev Growth | — | +19.5% | +13.8% |
| Debt/Equity | — | 0.24 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |